Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- 5 Years Too Long to Achieve Reference Generic Share Target of 60%: Bill Payer Reps at CSIMC Subcommittee
February 28, 2013
- Shuji Shirakawa of Kenporen Says Long-Listed Product Price Cuts Irrelevant to New Drug Development Premium
February 28, 2013
- Participation in TPP Talks “Will Not Damage” Japan’s Universal Health Insurance System: Health Minister Tamura
February 27, 2013
- PAFSC’s 2nd Committee Recommends Approval for CMIC’s Acute Porphyria Treatment
February 27, 2013
- JMACCT Revamps Database of Clinical Trial Institutions; Details Now Available Online
February 27, 2013
- MHLW Launches HQ to Promote Health and Medical Strategy
February 27, 2013
- Doctors' Average Monthly Wage Reaches 789,300 Yen in 2012, MHLW Survey Shows
February 25, 2013
- Govt Launches New Office of Health and Medical Strategy
February 25, 2013
- Ruling Parties’ Commission on Reduced Consumption Tax Rate System to Issue Interim Report This Summer
February 22, 2013
- MHLW Plans to Revise Ordinance within 2 to 3 Years to Allow Electronic Prescribing
February 22, 2013
- About 60% of Prefectures Won't Set Generic Share Targets in Medical Expenditure Optimization Plans
February 22, 2013
- MHLW to Examine Online OTC Drug Sales after Top Court Ruling
February 22, 2013
- EAD Director Kamata Calls for Early Price Settlements at Municipal Hospitals
February 21, 2013
- MHLW Eager to Submit Bill to Amend PAL to Diet by Summer, Councilor Hirayama Says
February 21, 2013
- Tokyo’s Katsushika Ward Allies with Wholesalers in Drug Procurement during Disasters
February 21, 2013
- Private-sector Members of Industrial Competitiveness Council Divided on Measures to Strengthen Innovation
February 20, 2013
- Prof. Morishita Calls for New Pricing System for Innovative Drugs; Doubling Prices Yielded by Current Cost Calculation Method
February 19, 2013
- 25 Companies Receive Approval for Generic Loxonin Tape, 11 Companies for Generic Calblock
February 19, 2013
- Regulatory Reform Council’s Priority Areas Include Health, Medicine; Discussion Topics to Be Set by Feb.-End
February 18, 2013
- Notification on Clinical Trial Documents and Records Cancels Previous Rules on Paper-Based “Original Documents and Duplicate Copies”
February 18, 2013
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…